Absci Corporation

ABSI

$9.75

Updated: 24/09/2026, 05:40:58

Market Cap

$1.65B

Sector

Healthcare

Industry

Biotechnology

Country

Stock valuation chart

One-year closing share-price history for ABSI

Company Profile

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

USD

NASDAQ

CEO: Sean McClain

Employees: 140

https://www.absci.com

Asset Summaries

Latest generated summaries for ABSI

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for ABSI.

Share price: $9.75
Market cap: $1.65B
Exchange: NASDAQ
Currency: USD
CEO: Sean McClain
Employees: 140
IPO date: 22/07/2021
Beta: 2.436
Last dividend: $0.00
Day range: $9.47 – $10.62
52-week range: $2.24 – $12.06
1-day performance: -9.01%
1-year performance: 335.04%
Current drawdown (1Y): -19.16%
CIK: 0001672688
CUSIP: 00091E109
ISIN: US00091E1091
Created: 07/12/2025, 01:53:53
Last update: 24/09/2026, 05:40:58

Track Absci Corporation with an AI analyst

See which prediction-market events move ABSI, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to ABSI from your Railway `news_articles` table.

Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript

Seeking Alpha • STOCK • 10/06/2026, 03:12:10

Absci Corporation (ABSI) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Seeking Alpha • STOCK • 05/06/2026, 19:22:54

Absci to Participate in Upcoming Investor Conferences

GlobeNewsWire • STOCK • 20/05/2026, 10:00:00

Absci (NASDAQ: ABSI) Insider Buys Shares Amidst Financial Challenges and Clinical Progress

Market Data • Market Data • 13/05/2026, 22:16:34

Absci Corporation (ABSI) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 08/05/2026, 10:01:21

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research • STOCK • 08/05/2026, 01:26:41

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewsWire • STOCK • 04/05/2026, 22:11:00

Absci Corporation (ABSI) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Seeking Alpha • STOCK • 21/04/2026, 17:40:37

Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201

Seeking Alpha • STOCK • 25/03/2026, 15:48:04

Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 24/03/2026, 21:54:48

Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research • STOCK • 24/03/2026, 19:26:08

Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Seeking Alpha • STOCK • 23/03/2026, 05:22:17